Guidelines International Network | Guidelines International Network (GIN)

Cystic fibrosis screening – Recommendation not to implement a screening program

MeSH Terms: Neonatal Screening
English Title Translation: Newborn screening for metachromatic leukodystrophy (MLD)
Publication Scope: screening
Countries of Application: Sweden
Guideline Publication Status: Published
Languages: Swedish
Authors: Socialstyrelsen
Publication Year: 2025

MeSH Terms: Cystic Fibrosis (C16.320.190); Cystic Fibrosis (C16.614.213); Infection (C01.539); Cystic Fibrosis (C06.689.202); Cystic Fibrosis (C08.381.187)
Publication Scope: assessment; management; treatment
Countries of Application: United Kingdom
Guideline Publication Status: Published
Languages: English
Authors: NICE (UK)
Publication Year: 2017

MeSH Terms
Guideline Contact: Ina Kopp ([email protected])
English Title Translation: cystinosis
Keywords: Cystinose, Kinder, Jugendliche, Erwachsene, Diagnostik, Therapie, Prävention, Multiorganbeteiligung, Cystinosis, children, adolescents, adults, medication, multiorgan involvement, E72, 5C60.1, Zystinose, Cystinspeicherkrankheit
Date for Review: 29/11/2029
Publication Date: 03/06/2025
Publication Scope: management
Countries of Application: Germany
Guideline Publication Status: Published
Languages: German
Authors: AWMF (DE)
Publication Year: 2025

MeSH Terms: Cystitis (C13.351.968.829.495); Anti-Bacterial Agents (D27.505.954.122.085); Women (M01.975); Cystitis (C12.777.829.495)
Publication Scope: treatment
Countries of Application: France
Guideline Publication Status: Published
Languages: French
Authors: HAS (FR)
Publication Year: 2016

MeSH Terms: Menopause (G08.686.785.880.249.500); Menopause (G08.686.157.500)
Guideline Contact: Jolanda Wittenberg ([email protected])
English Title Translation: Menopause
Publication Scope: assessment; management
Countries of Application: Netherlands
Guideline Publication Status: Published
Languages: Dutch
Authors: NHG (NL)
Publication Year: 2022

MeSH Terms: Mevalonate Kinase Deficiency (C16.320.382.750); Mevalonate Kinase Deficiency (C20.683.460.319); Mevalonate Kinase Deficiency (C15.378.147.542.319); Mevalonate Kinase Deficiency (C16.320.565.663.480); Mevalonate Kinase Deficiency (C16.320.565.189.680.430); Mevalonate Kinase Deficiency (C18.452.132.100.680.430); Mevalonate Kinase Deficiency (C18.452.648.189.680.430); Mevalonate Kinase Deficiency (C10.228.140.163.100.680.430)
Publication Scope: assessment; counselling; implementation; management; patient_education; prevention; rehabilitation; screening; treatment
Countries of Application: France
Guideline Publication Status: Published
Languages: French
Authors: HAS (FR)
Publication Year: 2015